A review of human and analogue insulin trials.
A recent meta-analysis evaluated trials of the rapid-acting analogues insulin lispro and insulin aspart, performed before the introduction of the basal analogues, insulin glargine and insulin detemir. This article reviews the effect of rapid-acting and basal insulin analogues separately and in combi...
Main Author: | Gough, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2007
|
Similar Items
-
Insulin therapy and body weight: benefits of biphasic human insulin analogue NovoMix 30
by: Elena Viktorovna Surkova
Published: (2013-03-01) -
Regular human insulins versus rapid-acting insulin analogues in children and adolescents with type 1 diabetes: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis
by: Johanne Juul Petersen, et al.
Published: (2025-01-01) -
Insulin degludec is a new ultra-long-acting insulin analogue
by: Ivan Ivanovich Dedov, et al.
Published: (2014-07-01) -
Insulin analogues and cancer: a note of caution
by: Joseph A.M.J.L. eJanssen, et al.
Published: (2014-05-01) -
Insulin degludec/insulin aspart is the first co-formulation of basal and prandial insulin analogues
by: Ivan Ivanovich Dedov, et al.
Published: (2014-12-01)